Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5862 posts found.

scott_gottlieb

FDA Commissioner Scott Gottlieb announces resignation

March 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid crisis, pharma

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
News
antony_loebel

Sunovion CMO Dr Antony Loebel made company’s new CEO

March 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …
Appointment
shutterstock_38078521

Akcea and Ionis’ Waylivra nets CHMP approval in ultra-rare familial chylomicronaemia syndrome

March 5, 2019 Manufacturing and Production, Sales and Marketing Akcea, FCS, Ionis, familial chylomicronemia syndrome, pharma, rare disease

Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra (volanesorsen) has been recommended by the EMA’s Committee …
News
novartis_side_building

Novartis set to offer 14 weeks paternity leave

March 5, 2019 Manufacturing and Production Novartis, company culture, paternity leave, work

Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of …
News
1920px-hiv-budding-color

London man becomes second in world to be cured of HIV

March 5, 2019 Manufacturing and Production Berlin Patient, CCR5, HIV, He Jiankui, London Patient

A man in Britain has become the second person in the world to be ‘cured’ of HIV, after receiving a …
News
novartis_side_building

Novartis’ Cosentyx tops Janssen’s Stelara in moderate-to-severe psoriasis trial

March 5, 2019 Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma, psoriasis

New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating the …
News
920x920

OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say

March 4, 2019 Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials

OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …
News

The cutting edge of cancer research

March 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, oncology

While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …
News
8b437d43644106a4fb11aa4292aa6fbd_1

Working Life: Nicola Redfern, UK General Manager, bluebird bio

February 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, Interview, Working Life, pharma

How did you find your way into the pharma industry? Was it always an aspiration of yours? My mum worked …
Feature

Vaccine biotech Emergex name experienced pharma professional Dr Athanasios Papadopoulos as new CMO

February 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Emergex Vaccine Holdings Limited has named Dr Athanasios Papadopoulos as the company’s new Chief Medical Officer (CMO). The appointment, effective …
Appointment
patrick_chinnery

Professor Patrick Chinnery named as Clinical Director of MRC

February 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Professor Patrick Chinnery has been appointed to the role of Clinical Director at the Medical Research Council (MRC) the non-departmental …
Appointment
pharmafocus_march_2019_cover

Read the March 2019 issue of Pharmafocus online now!

February 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Drug pricing, HIV, Trump, WHO, brexit, depression, mental health, pharmacovigilance, rare disease

Just one month to go until Brexit here in the UK, and it’s still all to play for. After months …
News
shutterstock_274590824

Jury upholds Amgen’s patent validity for Repatha, deflecting challenge from Sanofi and Regeneron

February 26, 2019 Manufacturing and Production, Sales and Marketing Amgen, Regeneron, Repatha, Sanofi, patent, pharma

Amgen is celebrating after a Delaware jury backed the validity of two of its patents against challenges from Regeneron and …
News
neurons-3743011_960_720

Vitamin D deficiency may cause cognitive decline through weakening brain’s scaffolding

February 26, 2019 Manufacturing and Production NPP, mental health, neurology, neuroscience, schizophrenia, vitamin d

Vitamin D deficiency may weaken supportive ‘scaffolding’ in the brain thus causing neurons difficulty in maintaining connections, according to a …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026